Hyperphosphorylation of tau protein by calpain regulation in retina of Alzheimer's disease transgenic mouse

Neuroscience Letters

Volumn 551, Issue , 2013, Pages 12-16

  Zhao, Haikang ^a   Chang, Rui ^b   Che, Haijiang ^b   Wang, Jianbang ^a   Yang, Lei ^a   Fang, Wei ^c   Xia, Yi ^c   Li, Nan ^c   Ma, Quanrui ^d   Wang, Xuelian ^c  

^a XI'AN MEDICAL UNIVERSITY   (China)

^b Trauma Center   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer disease; Calpain; Cdk5; Phosphorylated tau; Tau pathology

Indexed keywords

BETA ACTIN; CALPAIN; CYCLIN DEPENDENT KINASE 5; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MOUSE; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SENILE PLAQUE; TISSUE PREPARATION; TRANSGENIC MOUSE; UPREGULATION; WESTERN BLOTTING;

ALZHEIMER DISEASE; CALPAIN; CDK5; PHOSPHORYLATED TAU; TAU PATHOLOGY;

ALZHEIMER DISEASE; ANIMALS; CALPAIN; DISEASE MODELS, ANIMAL; MICE; MICE, TRANSGENIC; NEUROFIBRILLARY TANGLES; PHOSPHORYLATION; PLAQUE, AMYLOID; RETINA; TAU PROTEINS;

EID: 84882284105     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.06.026     Document Type: Article

References (30)

1. Bassil N., Mollaei C. Alzheimer's disease dementia: a brief review. J. Med. Liban. 2012, 60:192-199.
2. Galimberti D., Scarpini E. Progress in Alzheimer's disease. J. Neurol. 2012, 259:201-211.
3. Kitazawa M., Cheng D., Laferla F.M. Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates Cdk5 in a mouse model of AD. J. Neurochem. 2009, 108:1550-1560.
4. Manukhina E.B., Goryacheva A.V., Barskov I.V., Viktorov I.V., Guseva A.A., Pshennikova M.G., Khomenko I.P., Mashina S.Y., Pokidyshev D.A., Malyshev I.Y. Prevention of neurodegenerative damage to the brain in rats in experimental Alzheimer's disease by adaptation to hypoxia. Neurosci. Behav. Physiol. 2010, 40:737-743.
5. Cancino G.I., Perez de Arce K., Castro P.U., Toledo E.M., von Bernhardi R., Alvarez A.R. c-Abl tyrosine kinase modulates tau pathology and Cdk5 phosphorylation in AD transgenic mice. Neurobiol. Aging 2009, 32:1249-1261.
6. Engmann O., Giese K.P. Crosstalk between Cdk5 and GSK3beta: implications for Alzheimer's disease. Front. Mol. Neurosci. 2009, 2:2.
7. Mazanetz M.P., Fischer P.M. Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases. Nat. Rev. Drug Discov. 2007, 6:464-479.
8. Iqbal K., Grundke-Iqbal I. Discoveries of tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: a personal historical perspective. J. Alzheimers Dis. 2006, 9:219-242.
9. Higuchi M., Iwata N., Matsuba Y., Takano J., Suemoto T., Maeda J., Ji B., Ono M., Staufenbiel M., Suhara T., Saido T.C. Mechanistic involvement of the calpain-calpastatin system in Alzheimer neuropathology. FASEB J. 2012, 26:1204-1217.
10. Guo L., Duggan J., Cordeiro M.F. Alzheimer's disease and retinal neurodegeneration. Curr. Alzheimer Res. 2010, 7:3-14.
11. Chiu K., Chan T.F., Wu A., Leung I.Y., So K.F., Chang R.C. Neurodegeneration of the retina in mouse models of Alzheimer's disease: what can we learn from the retina. Age (Dordr) 2012, 34:633-649.
12. Ikram M.K., Cheung C.Y., Wong T.Y., Chen C.P. Retinal pathology as biomarker for cognitive impairment and Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2012, 83:917-922.
13. Frost S., Martins R.N., Kanagasingam Y. Ocular biomarkers for early detection of Alzheimer's disease. J. Alzheimers Dis. 2010, 22:1-16.
14. Devi L., Ohno M. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice. Eur. J. Neurosci. 2010, 31:110-118.
15. Kril J.J., Patel S., Harding J., Halliday G.M. Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation. Acta Neuropathol. 2002, 103:370-376.
16. Lai M.K.P., Chen C.P., Hope T., Esiri M.M. Hippocampal neurofibillary tangle changes and aggressive behaviour in dementia. Neuroreport 2010, 21:1111-1115.
17. Valenti D.A. Alzheimer's disease: visual system review. Optometry 2010, 81:12-21.
18. Chen S.T., Wang J.P., Chien C.H., Shen C.L. Differential expression of beta-amyloid precursor and Bcl-2 proto-oncogene proteins in the developing dog retina. Neurosci. Res. 1999, 35:265-271.
19. Li G., Percontino L., Sun Q., Qazi A.S., Frederekse P.H. Beta-amyloid secretases and beta-amloid degrading enzyme expression in lens. Mol. Vis. 2003, 9:179-183.
20. Alexandrov P.N., Pogue A., Bhattacharjee S., Lukiw W.J. Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease. Neuroreport 2011, 22:623-627.
21. S. Saidha, E.S. Sotirchos, J. Oh, S.B. Syc, M.A. Seigo, N. Shiee, C. Eckstein, M.K. Durbin, J.D. Oakley, S.A. Meyer, T.C. Frohman, S. Newsome, J.N. Ratchford, L.J. Balcer, D.L. Pham, C.M. Crainiceanu, E.M. Frohman, D.S. Reich, P.A. Calabresi, Relationship between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis, JAMA Neurol. 70 (2013) 34-43.
22. Zueva M.V. Maturation and plasticity of visual system: neurogenesis, synaptogenesis, and myelogenesis. Report I. Retina and retinogeniculate projections. Vestn. Oftalmol. 2012, 128:37-41.
23. Ohno-Matsui K. Parallel findings in age-related macular degeneration and Alzheimer's disease. Prog. Retina Eye Res. 2011, 30:217-238.
24. Lee V.M., Balin B.J., Otvos L., Trojanowski J.Q. A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 1999, 251:675-678.
25. Busciglio J., Lorenzo A., Yankner B.A. beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 1995, 14:879-888.
26. Lopes J.P., Oliveira C.R., Agostinho P. Neurodegeneration in an Abeta-induced model of Alzheimer's disease: the role of Cdk5. Aging Cell 2010, 9:64-77.
27. Chaudhary P., Suryakumar G., Prasad R., Singh S.N., Ali S., Llavazhagan G. Chronic hypobaric hypoxia mediated skeletal muscle atrophy: role of ubiquitin-proteasome pathway and calpains. Mol. Cell. Biochem. 2012, 364:101-113.
28. Grammer M., Li D., Arunthavasothy N., Lipski J. Contribution of calpain activation to early stages of hippocampal damage during oxygen-glucose deprivation. Brain Res. 2008, 1196:121-130.
29. Lee M.S., Kwon Y.T., Li M., Peng J., Friedlander R.M., Tsai L.H. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 2000, 405:360-364.
30. S. Sato, J. Xu, S. Okuyama, L.B. Martinez, S.M. Walsh, M.T. Jacobsen, R.J. Swan, J.D. Schlautman, P. Ciborowski, T. Ikezu, Spatial learning impairment, enhanced 331 Cdk5/p35 activity, and downregulation of NMDA receptor expression in 332 transgenic mice expressing tau-tubulin kinase 1, J. Neurosci. 28 (2008) 333 14511-14521.